Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03329269
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
IDZ | 3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE | A | 2C3L | 0.71 | |
LL1 | 3-pyridin-4-yl-1H-indazole | A | 3DNE | 0.7 | |
L02 | 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL- 5-YL]PIPERIDINE | B,I | 1WAY | 0.76 | |
DZO | 3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5- a]pyrimidin-5-amine | A | 3E7V | 0.76 | |
5B2 | 5-phenyl-1H-indazol-3-amine | A | 3E63 | 0.75 | |
501 | N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)- 5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE- 2,7-DIAMINE | A,B | 1ZGV | 0.73 | |
QPP | N-(5-METHYL-1H-PYRAZOL-3-YL)-2- PHENYLQUINAZOLIN-4-AMINE | A,C | 2JC6 | 0.73 | |
5B1 | 5-bromo-1H-indazol-3-amine | A | 3E62 | 0.72 | |
SC8 | 5-(2,3-dichlorophenyl)-N-(pyridin- 4-ylmethyl)pyrazolo[1,5-a]pyrimidin- 7-amine | A | 2R3F | 0.73 | |
FRZ | 5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN- 3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN- 3-AMINE | A | 1TVO | 0.73 | |
UN3 | (2-METHYL-5-PHENYL-2H-PYRAZOL-3- YL)-SULFAMIC ACID | A | 2F6W | 0.71 | |
P19 | N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE- 2,4-DIAMINE | A | 2PVH | 0.7 | |
P45 | 2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5- A][1,3,5]TRIAZINE-8-CARBONITRILE | A | 2PVK | 0.79 | |
F29 | 1-ALLYL-5-(2-PHENYLPYRAZOLO[1,5- A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4- C]PYRIDAZIN-3-AMINE | A | 1WZY | 0.7 | |
5CP | [4-({4-[(5-cyclopropyl-1H-pyrazol- 3-yl)amino]-6-(methylamino)pyrimidin- 2-yl}amino)phenyl]acetonitrile | A,B | 3BHH | 0.71 | |
BMU | 1-(5-TERT-BUTYL-2-METHYL-2H-PYRAZOL- 3-YL)-3-(4-CHLORO-PHENYL)-UREA | A | 1KV1 | 0.77 | |
GVD | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL- 3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA- 2,5-DIEN-1-YL]ACETONITRILE | A | 2UV2 | 0.71 | |
GVD | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL- 3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA- 2,5-DIEN-1-YL]ACETONITRILE | A,B | 3GGF | 0.71 | |
GVD | [4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL- 3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA- 2,5-DIEN-1-YL]ACETONITRILE | A,B | 2VN9 | 0.71 | |
PP2 | 1-TERT-BUTYL-3-(4-CHLORO-PHENYL)- 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE | A,B | 3GEQ | 0.76 | |
PP2 | 1-TERT-BUTYL-3-(4-CHLORO-PHENYL)- 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE | A | 2ZV9 | 0.76 | |
PP2 | 1-TERT-BUTYL-3-(4-CHLORO-PHENYL)- 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-YLAMINE | A | 1QPE | 0.76 | |
928 | 5-amino-1-(4-chlorophenyl)-1H-pyrazole- 4-carbonitrile | A | 3EJ2 | 0.71 | |
LZ1 | 1H-indazole | A,B | 3E6I | 0.71 | |
LZ1 | 1H-indazole | A | 2VTA | 0.71 | |
D15 | N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}- 1H-indazol-3-yl)benzamide | A,B,C,D | 2VX3 | 0.75 | |
P44 | 2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5- A][1,3,5]TRIAZINE-8-CARBONITRILE | A | 2PVJ | 0.73 |